leisure time -WSS

leisure time

author：hotspot 2025-09-30 14:08:11 - browse：98

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： The system is set up to fail children with medical complexity

entertainment

WSS

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Statins may not be needed by millions of people, study suggests

30 years of 'Listening to Prozac'

Teladoc has a new CEO, but challenges remain the same

How faith leaders like me can help address America's obesity epidemic

Organ aging and disease risk measured by new blood test

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

At least 13 dead in Texas as scorching temps continue

What don’t we know about an Alzheimer’s drug side effect?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cheap, fast test for Zika and dengue could cost just $1

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Drug repurposing or repositioning? The language matters

Pediatric cancer treatments threatened by a new FDA policy

How one medical school became remarkably diverse

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

hotspot

U.K. Biobank has 500,000 peoples' genome sequences available

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Organ aging and disease risk measured by new blood test

Health care court cases: Humana, Sutter, Novant

STAT Virtual Event: ASCO Recap, Live!

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

entertainment

focus

focus

Wikipedia